IOL uses wavefront modifications to help patients with early-stage maculopathies

VIENNA — A newly designed IOL, using longitudinal and transverse asphericity to increase depth of focus, shows benefits in patients with cataract and macular disease at the early stages.
“The EyeMax lens (LEH Pharma) is not a magnifying lens, nor a prism,” Federico Badalà, MD, said at the European Society of Cataract and Refractive Surgeons meeting. “It introduces a new concept in the field of AMD-designed IOLs, using for the first time both longitudinal and transversal asphericity to increase depth of focus.”
The lens is engineered to project well-focused

Full Story →